Plenary Lecture:

Ming Xian, PhD

Jesse H. Metcalf Professor of Chemistry at Brown University

Chemical Tools for Regulating Reactive Sulfur Species in Redox Biology

Plenary Lecture:

Joshua Kritzer, PhD

Professor, Director of Graduate Studies, Department of Chemistry at Tufts University

Chemical Biology Tools for Measuring Intracellular Drug Delivery

Kevin Filipski, PhD

Associate Research Fellow @ Pfizer

The First BDK Inhibitor/Degrader Clinical Candidate, PF-07328948, as a Treatment of Heart Failure

Martin Himmelbauer, PhD

Principal Scientist @ Biogen

Discovery of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK-Inhibitor for the Treatment of MS

Karthik Iyer, PhD

Director, Medicinal Chemistry @ Arrakis Therapeutics

Drugging MYC mRNA with Small Molecules

Colin (Jianglin) Liang, PhD

Senior Director, Process Chemistry, CMC @ Tango Therapeutics

Development of a Commercial-Ready Process for TNG908, a Potent, Selective, and Brain Penetrant MTA-Cooperative PRMT5 Inhibitor

Abba Leffler, PhD

Senior Principal Scientists, Drug Discovery Group @ Schrodinger

Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations 

Teresa Mako, PhD

Senior Scientist, Medicinal Chemistry @ Orum Therapeutics

PROTAb Platform: An Innovative Universal Linker for DACs with CRBN-Based Degraders

Mark Mantell, PhD

Scientist @ GSK

DNA Encoded Libraries – Drug Discovery through DEL screening and the Application of On-DNA Binder Confirmation

Brandon Vara, PhD

Associate Principal Scientist, Discovery Chemistry @ Merck Research Laboratories

Discovery of MK-4424: An Exquisitely Selective, Potent & CNS-Penetrant RIPK1 Type-III Inhibitor

Daniel Smaltz, PhD

Associate Research Fellow, Medicinal Chemistry, @ Pfizer

Discovery and Optimization of a Series of MALT1 Inhibitors Using Structure-Based Drug Design and Parallel Medicinal Chemistry